Abstract
Background
Nitidine chloride (NC) is known to exert anticancer and anti-metastatic effects on a variety of tumors. Recently, NC has also been shown to inhibit PIK3/AKT/mTOR axis in U87 human glioma cells.
Methods
The study shows NC employing pDok2, caspase 3 dependent cell death in C6 rat glioma and U87 human malignant glioblastoma cells. The effect of NC on glioblastoma cell lines was accessed by MTT, clonogenic and wound healing assays. Cell cycle analysis was performed by FACS. Moreover, the effect of NC on downstream target proteins, such as caspase3, pDok2, PARP, and Gsk3 beta, were measured by western blotting.
Results
Overexpressed pDok2 protein has recently been reported as a prognostic marker with poor outcomes for human glioblastoma multiformae. We found that NC inhibits pDok2 in U87 cells in a concentration-dependent way. We further showed that cleaved PARP and cleaved caspase 3 protein expressions were increased in C6 cells treated with NC in a dose-dependent way. NC effectively attenuated C6 cells growth and colony formation at 8 μM (micromoles) concentration. Cell cycle arrest in G2/M phase was further confirmed by flow cytometry. NC also exhibited its inhibitory effect on Gsk3 beta, which has been proven to be altered in glioma biology.
Conclusions
Collectively, we predicted that NC could be employed as a potential anti-glioma mediator that needs attention to explore the mechanisms of its activity.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 2016;131(6):803–20.
Deshpande RP, Babu D, Panigrahi M, Chandra Sekhar YB, Prakash Babu P. Brain tumors incidences and a retrospective clinical analysis from a tertiary hospital in India. J Neurooncol 2016;129(2):383–7.
Chandana SR, Movva S, Arora M, Singh T. Primary brain tumors in adults. Am Fam Physician 2008;77(10):1423–30.
National cancer Institute. Statistics for year. 2015. http://seer.cancer.gov/statfacts/html/brain.html.
Hu J, Zhang WD, Liu RH, Zhang C, Shen YH, Li HL, et al. Benzophe-nanthridine alkaloids from Zanthoxylum nitidum (Roxb.) DC, and their analgesic and anti-inflammatory activities. Chem Biodivers 2006;3:990–5.
Fang Z, Tang Y, Jiao W, Xing Z, Guo Z, Wang W, et al. Nitidine chloride induces apoptosis and inhibits tumor cell proliferation via suppressing erk signaling pathway in renal cancer. Food Chem Toxicol 2014;66:210–6.
Liao J, Xu T, Zheng JX, Lin JM, Cai QY, Yu DB, et al. Nitidine chloride inhibits hepatocellular carcinoma cell growth in vivo through the suppression of the jak1/stat3 signaling pathway. Int J Mol Med 2013;32(1):79–84.
Pan X, Han H, Wang L, Yang L, Li R, Li Z, et al. Nitidine chloride inhibits breast cancer cells migration and invasion by suppressing c-src/fak associated signaling pathway. Cancer Lett 2011;313:181–91.
Liu M, Wang J, Qi Q, Huang B, Chen A, Li X, et al. Nitidine chloride inhibits the malignant behavior of human glioblastoma cells by targeting the PI3K/AKT/ mTOR signaling pathway. Oncol Rep 2016;36(4):2160–8.
Qian J, Zou Y, Rahman JS, Lu B, Massion PP. Synergy between phosphatidylinositol 3-kinase/Akt pathway and Bcl-xL in the control of apoptosis in adenocarcinoma cells of the lung. Mol Cancer Ther 2009;8:101–9.
Chen J, Wang J, Lin L, He L, Wu Y, Zhang L, et al. Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer. Mol Cancer Ther 2012;11:277–87.
Fang Z, Tang Y, Jiao W, Xing Z, Guo Z, Wang W, et al. Nitidine chloride inhibits renal cancer cell metastasis via suppressing AKT signaling pathway. Food Chem Toxicol 2013;60:246–51.
Wen X, Zhou M, Guo Y, Zhu Y, Li H, Zhang L, et al. Expression and significance of DOK2 in colorectal cancer. Oncol Lett 2015;9(1):241–4.
Miyagaki H, Yamasaki M, Takahashi T, Kurokawa Y, Miyata H, Nakajima K, et al. DOK2 as a marker of poor prognosis of patients with gastric adenocarcinoma after curative resection. Ann Surg Oncol 2012;19:1560–7.
Deshpande RP, Chandra Sekhar YB, Panigrahi M, Babu PP. Region specific Dok2 overexpression associates with poor prognosis in human astrocytoma. Mol Neurobiol 2016, doi:http://dx.doi.org/10.1007/s12035-016-0324-2.
Galia A, Calogero AE, Condorelli R, Fraggetta F, La Corte A, Ridolfo F, et al. PARP-1 protein expression in glioblastoma multiforme. Eur J Histochem 2012;56(1):e9, doi:http://dx.doi.org/10.4081/ejh.2012.e9.
Venere M, Hamerlik P, Wu Q, Rasmussen RD, Song LA, Vasanji A, et al. Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells. Cell Death Differ 2014;21(2):258–69.
Stegh AH, Kesari S, Mahoney JE, Jenq HT, Forloney KL, Protopopov A, et al. Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma. Proc Natl Acad Sci U S A 2008;105(31):10703–8.
Sun M, Zhang N, Wang X, Cai C, Cun J, Li Y, et al. Nitidine chloride induces apoptosis, cell cycle arrest, and synergistic cytotoxicity with doxorubicin in breast cancer cells. Tumour Biol 2014;35(10):10201–12, doi:http://dx.doi.org/10.1007/s13277-014-2327-9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Deshpande, R.P., Babu, P.P. pDok2, caspase 3 dependent glioma cell growth arrest by nitidine chloride. Pharmacol. Rep 70, 48–54 (2018). https://doi.org/10.1016/j.pharep.2017.07.013
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.pharep.2017.07.013